Table 2.
The prevalence of frailty based on Fried frailty phenotype according of age groups and genders.
| Variables | Total Participants (%) N = 2392 | Female (%) N = 1235 | Male (%) N = 1157 | |||
|---|---|---|---|---|---|---|
| Pre-frailty N = 1026 | Frailty N = 193 | Pre-frailty N = 602 | Frailty N = 119 | Pre-frailty N = 424 | Frailty N = 74 | |
| Age groups | Point estimation (95% CI) | Point estimation (95% CI) | Point estimation (95% CI) | Point estimation (95% CI) | Point estimation (95% CI) | Point estimation (95% CI) |
| 60–64 years | 37.29 (33.60–41.13) | 4.18 (2.83–6.13) | 47.13 (41.90–52.43) | 6.37 (4.17–9.61) | 26.41 (21.55–31.92) | 1.76 (0.74–4.13) |
| 65–69 years | 48.10 (44.92–51.30) | 4.84 (3.57–6.54) | 58.40 (54.20–62.48) | 6.30 (4.48–8.77) | 35.45 (30.93–40.24) | 3.05 (1.65–5.58) |
| 70–74 years | 52.38 (47.35–57.36) | 10.58 (7.92–13.99) | 61.80 (54.45–62.48) | 18.54 (13.63–24.71) | 44.00 (37.48–50.73) | 3.50 (1.69–7.10) |
| 75–79 years | 57.09 (51.64–62.38) | 19.50 (15.44–24.32) | 59.85 (51.95–67.26) | 28.79 (22.12–36.52) | 54.66 (47.15–61.97) | 11.33 (7.27–17.24) |
| 80–84 years | 60.27 (52.02–67.98) | 27.40 (20.89–35.03) | 56.52 (44.15–68.13) | 36.23 (25.89–48.03) | 63.64 (52.23–73.69) | 19.48 (12.04–29.95) |
| ≥ 85 years | 32.35 (22.27–44.39) | 57.35 (45.56–68.36) | 32.50 (20.10–47.95) | 65.00 (49.53–77.85) | 32.14 (17.32–51.71) | 46.43 (29.72–63.98) |
| All age groups* | 46.04 (43.95–48.15) | 12.36 (11.15–13.68) | 53.59 (50.77–56.39) | 16.73 (14.86–18.79) | 38.49 (35.50–41.58) | 7.98 (6.41–9.90) |
| All age groups** | 46.76 (44.72–48.81) | 12.07 (10.89–13.36) | 54.19 (51.39–56.95) | 16.84 (14.95–18.91) | 38.63 (35.75–41.59) | 7.34 (5.91–9.07) |
*Age and sex standardized based on the Iranian population in 2016.
**Age-standardized based on World Health Organization Population 2000–2025.